{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:57:45Z","timestamp":1787500665428,"version":"build-2736575974"},"reference-count":10,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Dolutegravir is an integrase inhibitor in first-line antiretroviral therapy in South Africa. We describe a patient who developed severe drug-induced liver injury on dolutegravir-containing antiretroviral treatment, in whom liver biopsy demonstrated subacute hepatic necrosis, non-necrotising granulomatous inflammation, and bile duct injury: an uncommon histological pattern in dolutegravir-associated hepatotoxicity.<\/jats:p>","DOI":"10.4102\/sajhivmed.v27i1.1817","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:37:57Z","timestamp":1782391077000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Not your usual drug-induced liver injury: Dolutegravir-associated granulomatous hepatitis"],"prefix":"10.4102","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5603-7208","authenticated-orcid":false,"given":"Muhammed","family":"Vally","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5622-4692","authenticated-orcid":false,"given":"Muhammad","family":"Ayob","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-014X","authenticated-orcid":false,"given":"Adam","family":"Mahomed","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-3616","authenticated-orcid":false,"given":"Kairoonisha","family":"Mahomed","sequence":"additional","affiliation":[{"name":"Private Practice, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5451-749X","authenticated-orcid":false,"given":"Washington","family":"Mudini","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2543-7025","authenticated-orcid":false,"given":"Vikash","family":"Lala","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rp50x72","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Witwatersrand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"McCormack PL. Dolutegravir: A review of its use in the management of HIV-1 infection in adolescents and adults. Drugs. 2014;74(11):1241\u20131252. https:\/\/doi.org\/10.1007\/s40265-014-0256-y","DOI":"10.1007\/s40265-014-0256-y"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Wang B, Abbott L, Childs K, et al. Dolutegravir-induced liver injury leading to sub-acute liver failure requiring transplantation: A case report and review of the literature. Int J STD AIDS. 2018;29(4):414\u2013417. https:\/\/doi.org\/10.1177\/0956462417734099","DOI":"10.1177\/0956462417734099"},{"key":"ref2","unstructured":"Mir-Madjlessi SH, Farmer RG, Hawk WA. Spectrum of hepatic manifestations of granulomatous hepatitis of unknown etiology. Am J Gastroenterol. 1974;62(3):221\u2013229."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Christensen ES, Jain R, Roxby AC. Abacavir\/dolutegravir\/lamivudine (Triumeq)-induced liver toxicity in a human immunodeficiency virus-infected patient. Open Forum Infect Dis. 2017;4(3):ofx122. https:\/\/doi.org\/10.1093\/ofid\/ofx122","DOI":"10.1093\/ofid\/ofx122"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Fontana RJ, Liou I, Reuben A, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2023;77(3):1036\u20131065. https:\/\/doi.org\/10.1002\/hep.32689","DOI":"10.1002\/hep.32689"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR. ACG clinical guideline: Diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021;116(5):878\u2013898. https:\/\/doi.org\/10.14309\/ajg.0000000000001259","DOI":"10.14309\/ajg.0000000000001259"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Lamps LW. Hepatic granulomas, with an emphasis on infectious causes. Adv Anat Pathol. 2008;15(6):341\u2013353. https:\/\/doi.org\/10.1097\/PAP.0b013e31818a6477","DOI":"10.1097\/PAP.0b013e31818a6477"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169\u2013176. https:\/\/doi.org\/10.1002\/hep.22322","DOI":"10.1002\/hep.22322"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"International AIH Pathology Group. Histopathological criteria for autoimmune hepatitis: Consensus recommendations from the International AIH Pathology Group. J Hepatol. 2022;77(4):1230\u20131245. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.012","DOI":"10.1016\/j.jhep.2022.05.012"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Danan G, Benichou C. Causality assessment of adverse reactions to drugs \u2013 I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323\u20131330. https:\/\/doi.org\/10.1016\/0895-4356(93)90101-6","DOI":"10.1016\/0895-4356(93)90101-6"}],"container-title":["Southern African Journal of HIV Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:38:12Z","timestamp":1782391092000},"score":1,"resource":{"primary":{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/view\/1817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/sajhivmed.v27i1.1817","relation":{},"ISSN":["1608-9693","2078-6751"],"issn-type":[{"value":"1608-9693","type":"print"},{"value":"2078-6751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"a1817"}}